Contest Details
Maker in China SME Innovation and Entrepreneurship Global Contest
Top 10

Novel anti-hypertensive drug development (KSD179019)

Company Details
Region Of Origin Founder
Hong Kong
Cyberport Community Status
Business Details
Technology Sector

PhrmaSec Limited is a Hong Kong University-based biotech spin-off company, rooted in the research done at Professor Billy KC Chow’s lab. Research led by Professor Chow and other groups has demonstrated that Secretin knockout animals will develop hypertension and related disorders as Secretin is of vital importance in water/salt homeostasis. Therefore, at PhrmaSec, by using an innovative approach, state-of-the-art technology and high-throughput in vitro and in silico screening, we have identified five therapeutic molecules that can target Secretin Receptor to function as anti-hypertensive compounds. KSD171990 is being selected for pre-clinical studies after comparison is made.

About iStartup

iStartup@HK, a one-stop platform run by Cyberport, is designed to connect tech start-ups to investors and users seeking innovative solutions. Through this virtual-pitching channel, tech companies can showcase their profile and products to attract funding and expand their business footprint.

    cyberport@HK logo